Diet-Induced Obesity Tumor Models for Cancer Studies

June 14, 2023

Diet-Induced Obesity Tumor Models for Cancer Studies

Obesity is a growing health concern worldwide. According to research, it is associated with an increased risk for cancer of at least 13 anatomic sites, including endometrial, esophageal, renal and pancreatic adenocarcinomas; hepatocellular carcinoma; gastric cardia cancer; meningioma; multiple myeloma; colorectal, postmenopausal breast, ovarian, gallbladder and thyroid cancers. Although the mechanism of this relationship is unclear, the existence of diet-based therapies (ketotherapy) as a form of cancer treatment suggests that diet somehow affects the activities of cancer cells or its environment. Preclinical studies are underway to gain a better understanding of how excess body weight affects the tumor microenvironment (TME) or how it impacts antitumor immunity.

Advancing Preclinical Research in Gynecologic Cancers

Gynecologic cancers, including endometrial and ovarian cancers, remain areas of high unmet need. Advances in targeted therapy, immunotherapy, ...

Read more +

History of CAR T-cells and Their Continued Use in Hematological Malignancies to Advance Next-Generation Therapies

CAR T-cell therapy originated in the late 1980s, first-generation constructs lacked adequate co-stimulatory signaling, causing poor CAR T-cell ...

Read more +

Cancer Support: Contract Research Organizations, More Than a Vendor, a Partner In Drug Development.

Developing cancer therapies is an incredibly complex, costly, and highly regulated journey. To navigate this challenging terrain, pharmaceutical and ...

Read more +

Get Started

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.